These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6047873)

  • 21. Influence of age and sex on hepatic lesions induced by chemical carcinogens: ingestion of N-4-(4'-fluorobiphenyl)acetamide by Buffalo strain rats.
    Stromberg K; Reuber MD
    J Natl Cancer Inst; 1970 May; 44(5):1047-54. PubMed ID: 5514470
    [No Abstract]   [Full Text] [Related]  

  • 22. Increased selectivity of interaction between fluorenylamine carcinogens and liver proteins during hepatocarcinogenesis.
    Sorof S; Young EM; McBride RZ; Coffey CB; Luongo L
    Mol Pharmacol; 1969 Nov; 5(6):625-39. PubMed ID: 5373894
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemical carcinogens and RNA.
    Weinstein IB; Grunberger D; Fujimura S; Fink LM
    Cancer Res; 1971 May; 31(5):651-5. PubMed ID: 5582124
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of partial hepatectomy and dietary phenobarbital on liver and mammary tumorigenesis by two N-hydroxy-N-acylaminobiphenyls in female CD rats.
    Shirai T; Lee MS; Wang CY; King CM
    Cancer Res; 1981 Jun; 41(6):2450-6. PubMed ID: 7237440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetylation of the carcinogen N-hydroxy-2-acetylaminofluorene by acetyl Coenzyme A to form a reactive ester.
    Lotlikar PD; Luha L
    Mol Pharmacol; 1971 Jul; 7(4):381-8. PubMed ID: 5113233
    [No Abstract]   [Full Text] [Related]  

  • 26. Lack of N-hydroxy-2-acetylaminofluorene sulfotransferase activity in the mammary gland and Zymbal's gland of the rat.
    Irving CC; Janss DH; Russell LT
    Cancer Res; 1971 Apr; 31(4):387-91. PubMed ID: 5553685
    [No Abstract]   [Full Text] [Related]  

  • 27. Reactivities of the carcinogens, N-hydroxy-2-fluorenylacetamide and N-hydroxy-3-fluorenylacetamide, with tissue nucleophiles.
    Zieve FJ; Gutmann HR
    Cancer Res; 1971 Apr; 31(4):471-6. PubMed ID: 5553692
    [No Abstract]   [Full Text] [Related]  

  • 28. The metabolic activation of carcinogenic aromatic amines and amides.
    Miller JA; Miller EC
    Prog Exp Tumor Res; 1969; 11():273-301. PubMed ID: 4888944
    [No Abstract]   [Full Text] [Related]  

  • 29. [The relevance of chemico-biological interactions for the toxic and carcinogenic effects of aromatic amines. I. Carcinogenic activity of some 4-aminostilbene and 4-aminobibenzyl-derivatives].
    Neumann HG; Metzler M; Brachmann I; Thomas C
    Z Krebsforsch; 1970; 74(2):200-6. PubMed ID: 4252986
    [No Abstract]   [Full Text] [Related]  

  • 30. Metabolism of the carcinogen N-hydroxy-N-2-fluorenylacetamide in germ-free rats.
    Weisburger JH; Grantham PH; Horton RE; Weisburger EK
    Biochem Pharmacol; 1970 Jan; 19(1):151-62. PubMed ID: 5507633
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of oral administration of N,N'-2,7-fluorenylenebisacetamide combined with traumatic ulcers of the glandular stomach of buffalo rats.
    Nagayo T
    J Natl Cancer Inst; 1965 Nov; 35(5):829-40. PubMed ID: 5849595
    [No Abstract]   [Full Text] [Related]  

  • 32. Activation of certain N-arylacetamides and N-arylacetohydroxamic acids in relation to mammary gland tumorigenesis in the rat.
    Malejka-Giganti D
    Natl Cancer Inst Monogr; 1981 Dec; (58):69-77. PubMed ID: 6804871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The significance of the age of rats in their sensitivity to the carcinogenic effect of 2-acetylaminofluorene].
    Vasil'eva IA
    Vopr Onkol; 1968; 14(8):58-63. PubMed ID: 5722194
    [No Abstract]   [Full Text] [Related]  

  • 34. A rapid and simple synthesis of reactive metabolites of carcinogenic aromatic amines in high yield.
    Westra JG
    Carcinogenesis; 1981; 2(4):355-7. PubMed ID: 7273317
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis and evaluation of N-(phenylalkyl)acetohydroxamic acids as potential substrates for N-arylhydroxamic acid N,O-acyltransferase.
    Elfarra AA; Yeh H; Hanna PE
    J Med Chem; 1982 Oct; 25(10):1189-92. PubMed ID: 7143355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiologic disposition of short chain aliphatic hydroxamates in the mouse. II. Absorption, distribution, metabolism and excretion of 1- 14C-acetohydroxamic acid.
    Fishbein WN; Streeter CL; Daly J
    J Pharmacol Exp Ther; 1973 Jul; 186(1):173-82. PubMed ID: 4723309
    [No Abstract]   [Full Text] [Related]  

  • 37. Recovery of radioactivity of N,N'-2,7-fluorenylenebisacetamide-9-C 14 from rats.
    Dyer HM; Lueders KK; Morris HP
    J Natl Cancer Inst; 1967 Jan; 38(1):93-101. PubMed ID: 6016645
    [No Abstract]   [Full Text] [Related]  

  • 38. [TUMOR PROGRESSION IN 2 MAMMARY CARCINOMAS IN RATS INDUCED WITH ACETYLAMINOFLUORENE].
    VANDENBERGHE H; VERRESEN H
    Bull Assoc Fr Etud Cancer; 1963; 50():291-303. PubMed ID: 14073504
    [No Abstract]   [Full Text] [Related]  

  • 39. Metabolism of the carcinogen N-2-fluorenylacetamide in germ-free and conventional rats.
    Grantham PH; Horton RE; Weisburger EK; Weisburger JH
    Biochem Pharmacol; 1970 Jan; 19(1):163-71. PubMed ID: 5507634
    [No Abstract]   [Full Text] [Related]  

  • 40. 4-guanidinobutyramide, a nonmetabolized pharmacologically active agent.
    Edelson J; Douglas JF; Ludwig BJ
    Arch Int Pharmacodyn Ther; 1972 May; 197(1):14-8. PubMed ID: 5031573
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.